In light of the July 4, 2013, recall of some 4.6 million skin-whitening prod- ucts that purportedly caused patchy skin lightening, de-pigmentation and vitiligo-like symptoms, the Japanese Ministry of Health, Labor and Welfare (MHLW) reportedly plans to amend its Pharmaceutical Affairs Law to improve its adverse effects reporting system for cosmetic products. The move follows the government’s criticism of manufacturer Kanebo Cosmetics Inc.’s handling of the recall; sources indicate that Kanebo was notified in mid-May that some consumers had experienced de-pigmentation after using the company’s skin-whitening products, but the cosmetics maker evidently neither reported those cases to the government until the end of June nor issued the recall until July. The law will reportedly be amended to require that Japanese cosmetic companies report severe adverse reactions to relevant authorities within 15 days of notification by consumers. Information about pending litigation against the company appears elsewhere in this Report. See and MHLW News Release, November 29, 2013.